News Call for ‘more trial, less error’ in study diversity A report from a UK think tank focused on the impact of longevity on society has found that people aged over 60 are still poorly represented in clinical trials – even thoug
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face